Clinical Trials Directory

Trials / Sponsors / Shanghai Jiatan Pharmatech Co., Ltd

Shanghai Jiatan Pharmatech Co., Ltd

Industry · 11 registered clinical trials — 7 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patie
Cervical Cancer Metastatic
Phase 32026-02-28
Not Yet RecruitingDrug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chines
Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 12025-05-12
RecruitingPharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects
TB
Phase 12024-09-04
RecruitingA Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma
Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
Phase 22023-08-25
RecruitingA Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors
Solid Tumor
Phase 1 / Phase 22022-11-18
RecruitingA Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patient
Rifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB)
Phase 32022-09-02
CompletedA Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations
PIK3CA Mutation-Related Tumors
Phase 1 / Phase 22021-06-03
RecruitingA Study of WX390 in Patients With Advanced Solid Tumors
Solid Tumor
Phase 22021-05-11
CompletedEvaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081
Pulmonary Tuberculosis
Phase 22020-10-16
CompletedSudapyridine (WX-081) in Healthy Volunteers
Healthy
Phase 12019-02-13
CompletedA Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma
Advanced Cancer
Phase 12018-10-25